Very interesting guys, I see the best way to compare the 2 is to look at MC before results were out FDA approved. DNDN were in rough terms $2-3 2009 and now 5.5bil at sp=$38 would give MC 0.29-0.430bil at this level/point in time. GIven parity with ex rate
SO we should get as high as 36-54c in aus. = $11-$16.2 on NASDAQ
HOWEVER this could be way undervalued since back then no one knew it was possible to get FDA approval!!!!!!!
AND
Prima has more products to sell
I could revise this based on prostate to ovarian market size. Has anyone got these figures?
Very interesting guys, I see the best way to compare the 2 is to...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 35.0¢ | 33.5¢ | $724.1K | 2.106M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 60483 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 55452 | 4 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |